Jack W. Singer
2018
In 2018, Jack W. Singer earned a total compensation of $1.3M as Former Executive Vice President, Chief Scientific Officer, Interim Chief Medical Officer and Global Head of Translational Medicine at CTI BioPharma, a 36% increase compared to previous year.
Compensation breakdown
| Option Awards | $271,514 |
|---|---|
| Salary | $269,744 |
| Other | $793,369 |
| Total | $1,334,627 |
Singer received $793.4K in other compensation, accounting for 59% of the total pay in 2018.
Singer also received $271.5K in option awards and $269.7K in salary.
Rankings
In 2018, Jack W. Singer's compensation ranked 7,750th out of 14,244 executives tracked by ExecPay. In other words, Singer earned more than 45.6% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 7,750 out of 14,244 | 46th |
Division Manufacturing | 3,024 out of 5,759 | 48th |
Major group Chemicals And Allied Products | 1,132 out of 2,122 | 47th |
Industry group Drugs | 955 out of 1,811 | 47th |
Industry Pharmaceutical Preparations | 744 out of 1,385 | 46th |
Source: SEC filing on April 4, 2019.
Singer's colleagues
We found three more compensation records of executives who worked with Jack W. Singer at CTI BioPharma in 2018.